This information was published on 2025-05-24T02:53:15 for Full Assignment - Subsequent Applicant Recorded Published.
| Field | Value |
| (210) | 2527948 (IR 1842234) |
| (220) |
06 Feb 2025
|
| (300) |
US, 19 Aug 2024, 98706329
|
| (511) (510) |
Class 5
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders. Class 42 Pharmaceutical research and development services. |
| (540) | GONDOLABIO |
| (550) | Word |
| (730) |
GondolaBio, LLC
|
Find out more about publications on the About page.